Regulation and patterns of endogenous and exogenous gene expression during differentiation of embryonal carcinoma cells.

por Astigiano, S, Sherman, M I, Abarzúa, P
Publicado 1989

Lateral Flexor Digitorum Longus Transfer for Peroneal Tendinopathy

por Sherman, Thomas I., Koury, Kimberly, Orapin, Jakrapong, Schon, Lew C.
Publicado 2019

Ankle Arthroscopy for Ankle Fractures

por Sherman, Thomas I., Casscells, Nick, Rabe, Joe, McGuigan, Francis X.
Publicado 2015

Mosaicism in von Hippel-Lindau disease: an event important to recognize

por Santarpia, Libero, Sarlis, Nicholas J, Santarpia, Mariacarmela, Sherman, Steven I, Trimarchi, Francesco, Benvenga, Salvatore
Publicado 2007

Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits

por Drucker, Daniel J., Sherman, Steven I., Gorelick, Fred S., Bergenstal, Richard M., Sherwin, Robert S., Buse, John B.
Publicado 2010

Challenges in the care of patients with RET-altered thyroid cancer: a multicountry mixed-methods study

por Murray, Suzanne, Subbiah, Vivek, Sherman, Steven I., Péloquin, Sophie, Sireci, Anthony, Grohé, Christian, Bubach, Patrick, Lazure, Patrice
Publicado 2023

Challenges in diagnosis and biomarker testing for RET-altered lung and thyroid cancer care: an international mixed-method study

por Lazure, Patrice, Sireci, Anthony, Subbiah, Vivek, Murray, Suzanne, Grohé, Christian, Sherman, Steven I., Kelly, Elizabeth, Bubach, Patrick, Péloquin, Sophie
Publicado 2023

Mid-Term Results after Lateral Transfibular Approach Total Ankle Arthroplasty

por Coleman, Michelle M., Abousayed, Mostafa, Netto, Cesar de Cesar, Lee, Moses, Maccario, Camilla, Sherman, Thomas I., Schon, Lew C.
Publicado 2022

SAT562 Metastatic Oncocytic (Formerly Hürthle Cell) Thyroid Carcinoma in a Patient With Birt-Hogg-Dubé Syndrome

por Vaid, Sonal, Klein, Rachael, Veeraraghavan, Padma, Blakaj, Dukagjin M, Agrawal, Amit, Sipos, Jennifer, Sherman, Steven I, Klubo-Gwiezdzinska, Joanna, Gubbi, Sriram
Publicado 2023

Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced o...

por Brose, Marcia S, Nutting, Christopher M, Sherman, Steven I, Shong, Young Kee, Smit, Johannes WA, Reike, Gerhard, Chung, John, Kalmus, Joachim, Kappeler, Christian, Schlumberger, Martin
Publicado 2011

No calcitonin change in a person taking dulaglutide diagnosed with pre‐existing medullary thyroid cancer

por Sherman, S. I., Kloos, R. T., Tuttle, R. M., Pontecorvi, A., Völzke, H., Harper, K., Vance, C., Alston, J. T., Usborne, A. L., Sloop, K. W., Lakshmanan, M.
Publicado 2018

MON-521 An Open-Label, Single-Arm, Multicenter, Phase 2 Trial of Lenvatinib (LEN) for the Treatment of Anaplastic Thyroid Cancer (ATC)

por Wirth, Lori J, Brose, Marcia S, Sherman, Eric J, Misir, Soamnauth, Xie, Sharon, Almonte, Ana, Ye, Weifei, Licitra, Lisa, Schlumberger, Martin, Sherman, Steven I, Cabanillas, Maria
Publicado 2020

Impact of baseline tumor burden on overall survival in patients with radioiodine‐refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial...

por Kiyota, Naomi, Tahara, Makoto, Robinson, Bruce, Schlumberger, Martin, Sherman, Steven I., Leboulleux, Sophie, Lee, Eun Kyung, Suzuki, Takuya, Ren, Min, Fushimi, Kazuma, Wirth, Lori J.
Publicado 2022

Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes

por Haddad, Robert I., Schlumberger, Martin, Wirth, Lori J., Sherman, Eric J., Shah, Manisha H., Robinson, Bruce, Dutcus, Corina E., Teng, Angela, Gianoukakis, Andrew G., Sherman, Steven I.
Publicado 2017

Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer

por Robinson, Bruce, Schlumberger, Martin, Wirth, Lori J., Dutcus, Corina E., Song, James, Taylor, Matthew H., Kim, Sung-Bae, Krzyzanowska, Monika K., Capdevila, Jaume, Sherman, Steven I., Tahara, Makoto
Publicado 2016

OR28-04 Identification of Novel and Rare Receptor Tyrosine Kinase Fusions in Thyroid Fine Needle Aspirates

por Wirth, Lori J, Grubbs, Elizabeth G, Livhits, Masha J, Sherman, Steven I, Weitzman, Steven P, Dosiou, Chrysoula, Ladenson, Paul W, Hao, Yangyang, Babiarz, Joshua E, Kennedy, Giulia C, Kloos, Richard T
Publicado 2020

Cabozantinib for previously treated radioiodine‐refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC‐311 trial

por Brose, Marcia S., Robinson, Bruce G., Sherman, Steven I., Jarzab, Barbara, Lin, Chia‐Chi, Vaisman, Fernanda, Hoff, Ana O., Hitre, Erika, Bowles, Daniel W., Sen, Suvajit, Oliver, Jennifer W., Banerjee, Kamalika, Keam, Bhumsuk, Capdevila, Jaume
Publicado 2022

MON-491 TRK-Fusion Thyroid Cancer: A Clinical Overview in a Large Population at a Single Cancer Center

por Fazeli, Sasan, Dadu, Ramona, Waguespack, Steven G, Sherman, Steven I, Busaidy, Naifa Lamki, Hu, Mimi I, Jimenez, Camilo, Habra, Mouhammed A, Williams, Michelle, Altameemi, Lina, Poropatich, Kate, Routbort, Mark J, Luthra, Raja, Patel, Keyur P, Cabanillas, Maria
Publicado 2020

Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer

por Wirth, Lori J., Brose, Marcia S., Sherman, Eric J., Licitra, Lisa, Schlumberger, Martin, Sherman, Steven I., Bible, Keith C., Robinson, Bruce, Rodien, Patrice, Godbert, Yann, De La Fouchardiere, Christelle, Newbold, Kate, Nutting, Christopher, Misir, Soamnauth, Xie, Ran, Almonte, Ana, Ye, Weifei, Cabanillas, Maria E.
Publicado 2021

Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study

por Cascone, T., Sacks, R.L., Subbiah, I.M., Drobnitzky, N., Piha-Paul, S.A., Hong, D.S., Hess, K.R., Amini, B., Bhatt, T., Fu, S., Naing, A., Janku, F., Karp, D., Falchook, G.S., Conley, A.P., Sherman, S.I., Meric-Bernstam, F., Ryan, A.J., Heymach, J.V., Subbiah, V.
Publicado 2021